Literature DB >> 28867886

Study of Effect of Vitamin D Supplementation on the Clinical, Hormonal and Metabolic Profile of the PCOS Women.

Taru Gupta1, Mukta Rawat1, Nupur Gupta1, Sarika Arora2.   

Abstract

INTRODUCTION: Insulin resistance is one of the most common features of polycystic ovary syndrome, and some studies suggest that vitamin D deficiency may have role in insulin resistance.
OBJECTIVE: To study the effect of vitamin D supplementation on the clinical, hormonal and metabolic profile of the PCOS women. STUDY
DESIGN: Randomized, placebo-controlled, interventional, double-blind study.
MATERIALS AND METHODS: PCOS women were evaluated and enrolled after considering inclusion and exclusion criteria. They were randomized by block randomization with sealed envelope system done in two groups. In the study group (n = 25), patients were supplemented with vitamin D 60,000 IU weekly for 12 weeks, whereas control group (n = 25) was given placebo weekly for the same period. Both the groups were compared pre- and post-supplementation for variables like clinical profile, biochemical profile and metabolic profile. Statistical analysis was performed by the SPSS program for Windows, version 10.1 (SPSS, Chicago, IL). RESULT: In the study (n = 50), PCOS patients were enrolled; 34 patients (68%) were vitamin D deficient (≤20 ng/ml) out of which 10 patients (29%) were severely deficient (<10 ng/ml). Twelve patients (24%) were vitamin D insufficient showing high prevalence of vitamin D deficiency in the PCOS women. The difference in mean serum fasting glucose pre- and post-supplementation of vitamin D in study group was found to be statistically significant with p value of 0.041. There was significant difference seen in insulin resistance (IR) (2.38 ± 4.88-1.00 ± 0.58, p = 0.003), serum fasting insulin (10.34 ± 20.00-5.00 ± 3.25, p = 0.021), and increase in insulin sensitivity determined by QUICKI (0.37 ± 0.04-0.394 ± 0.009, p = 0.001) after supplementation with vitamin D.
CONCLUSION: The study concluded that there was a beneficial effect of vitamin D supplementation on ovulatory dysfunctions and blood pressure. Post-supplementation, there were decrease in insulin resistance and increase in insulin sensitivity. In the study decreased serum fasting insulin level and fasting blood sugar after vitamin D supplementation suggest underlying role of vitamin D in glucose homeostasis.

Entities:  

Keywords:  Glucose homeostasis; Insulin resistance; PCOS; Vitamin D

Year:  2017        PMID: 28867886      PMCID: PMC5561752          DOI: 10.1007/s13224-017-1008-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  16 in total

1.  High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.

Authors:  Nazia Raja-Khan; Julie Shah; Christy M Stetter; Mary E J Lott; Allen R Kunselman; William C Dodson; Richard S Legro
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

2.  Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?

Authors:  Giovanna Muscogiuri; Caterina Policola; Annamaria Prioletta; Gianpio Sorice; Teresa Mezza; Annapia Lassandro; Silvia Della Casa; Alfredo Pontecorvi; Andrea Giaccari
Journal:  Clin Nutr       Date:  2012-01-20       Impact factor: 7.324

3.  Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.

Authors:  E Wehr; S Pilz; N Schweighofer; A Giuliani; D Kopera; T R Pieber; B Obermayer-Pietsch
Journal:  Eur J Endocrinol       Date:  2009-07-23       Impact factor: 6.664

4.  The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.

Authors:  Batool Rashidi; Fedieh Haghollahi; Mamak Shariat; Farid Zayerii
Journal:  Taiwan J Obstet Gynecol       Date:  2009-06       Impact factor: 1.705

5.  The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.

Authors:  H Selimoglu; C Duran; S Kiyici; C Ersoy; M Guclu; G Ozkaya; E Tuncel; E Erturk; S Imamoglu
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

6.  Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome.

Authors:  Kalliopi Kotsa; Maria P Yavropoulou; Olympia Anastasiou; John G Yovos
Journal:  Fertil Steril       Date:  2008-10-18       Impact factor: 7.329

Review 7.  Vitamin D status and arterial hypertension: a systematic review.

Authors:  Stefan Pilz; Andreas Tomaschitz; Eberhard Ritz; Thomas R Pieber
Journal:  Nat Rev Cardiol       Date:  2009-08-18       Impact factor: 32.419

Review 8.  Vitamin D, glucose, insulin, and insulin sensitivity.

Authors:  Kamilia Tai; Allan G Need; Michael Horowitz; Ian M Chapman
Journal:  Nutrition       Date:  2008-01-09       Impact factor: 4.008

9.  Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis.

Authors:  Jessica A Alvarez; Ambika Ashraf
Journal:  Int J Endocrinol       Date:  2010       Impact factor: 3.257

10.  Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.

Authors:  Hang Wun Raymond Li; Rebecca E Brereton; Richard A Anderson; A Michael Wallace; Clement K M Ho
Journal:  Metabolism       Date:  2011-05-06       Impact factor: 8.694

View more
  7 in total

1.  The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Karolina Łagowska; Joanna Bajerska; Małgorzata Jamka
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

2.  Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A SystematicReview of RCTs and Insight into the Underlying Mechanism.

Authors:  Shan Guo; Reshef Tal; Haoyu Jiang; Tao Yuan; Ying Liu
Journal:  Int J Endocrinol       Date:  2020-12-19       Impact factor: 3.257

3.  The relationship between Vitamin D deficiency and polycystic ovary syndrome.

Authors:  Feyzi Gokosmanoglu; Attila Onmez; Hasan Ergenç
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

4.  Association between serum 25-hydroxy vitamin D level and menstrual cycle length and regularity: A cross-sectional observational study.

Authors:  Vinita Singh; Neelam Tamar; Zamir Lone; Esha Das; Rajshree Sahu; Sagarika Majumdar
Journal:  Int J Reprod Biomed       Date:  2021-12-13

Review 5.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

6.  Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.

Authors:  Mazin H Daghestani; Maha H Daghestani; Arjumand Warsy; Afaf El-Ansary; Mohammed A Omair; Maha A Omair; Lena M Hassen; Eman Mh Alhumaidhi; Bashaer Al Qahtani; Abdel Halim Harrath
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

7.  The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.

Authors:  Majid Dastorani; Esmat Aghadavod; Naghmeh Mirhosseini; Fatemeh Foroozanfard; Shahrzad Zadeh Modarres; Mehrnush Amiri Siavashani; Zatollah Asemi
Journal:  Reprod Biol Endocrinol       Date:  2018-10-04       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.